Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Bioptik Technology, Inc. (4161) Financial Statements

Bioptik Technology, Inc. Financial Overview

Bioptik Technology, Inc.'s market cap is currently NT$1.22B. The company's EPS TTM is NT$1.86; its P/E ratio is 11.21; and it has a dividend yield of 3.36%. Bioptik Technology, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 837.19MNT$ 865.34MNT$ 828.50MNT$ 767.75MNT$ 737.89M
Gross ProfitNT$ 243.51MNT$ 267.90MNT$ 239.54MNT$ 177.46MNT$ 163.54M
Operating IncomeNT$ 66.73MNT$ 89.99MNT$ 90.25MNT$ 71.78MNT$ 27.14M
EBITDANT$ 99.50MNT$ 155.10MNT$ 152.18MNT$ 105.47MNT$ 64.41M
Net IncomeNT$ 71.19MNT$ 93.57MNT$ 85.71MNT$ 48.50MNT$ 22.59M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 448.38MNT$ 422.29MNT$ 394.13MNT$ 332.61MNT$ 344.85M
Total AssetsNT$ 1.57BNT$ 1.49BNT$ 1.50BNT$ 1.52BNT$ 1.52B
Total DebtNT$ 470.47MNT$ 451.02MNT$ 523.24MNT$ 662.87MNT$ 685.91M
Net DebtNT$ 71.17MNT$ 70.36MNT$ 154.63MNT$ 352.33MNT$ 582.02M
Total LiabilitiesNT$ 597.14MNT$ 582.47MNT$ 673.56MNT$ 797.40MNT$ 829.38M
Stockholders' EquityNT$ 969.36MNT$ 901.27MNT$ 819.34MNT$ 715.13MNT$ 690.25M
Cash Flow
Free Cash FlowNT$ 24.66MNT$ 143.32MNT$ 174.91MNT$ 37.98MNT$ -60.97M
Operating Cash FlowNT$ 43.83MNT$ 158.82MNT$ 205.95MNT$ 55.06MNT$ -41.15M
Investing Cash FlowNT$ -34.03MNT$ -12.44MNT$ -28.53MNT$ 187.14MNT$ -118.61M
Financing Cash FlowNT$ -964.00KNT$ -134.36MNT$ -119.33MNT$ -35.56MNT$ 5.65M

Currency in TWD

Bioptik Technology, Inc. Earnings and Revenue History

-500M0500M1B-24 %-12 %0 %12 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Bioptik Technology, Inc. Liabilities to Assets

0600M1.2B1.8B32 %40 %48 %56 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Bioptik Technology, Inc. Cash Flow

-200M-100M0100M200M300M2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Bioptik Technology, Inc. Forecast EPS vs Actual EPS

0.20.30.40.50.60.70.8Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss
Earnings >